Alvotech (ALVOW) Income from Continuing Operations (2021 - 2025)
Alvotech (ALVOW) reported Income from Continuing Operations of 309470000.0 for Q4 2025, up 252.25% on a YoY basis from 87854774.12 in Q4 2024, and up 212.19% quarter-over-quarter from 275853000.0 in Q3 2025.
Alvotech (ALVOW) Income from Continuing Operations (2021 - 2025) Analysis & Trends
Alvotech has reported Income from Continuing Operations for 5 years, with the latest figure at 309470000.0 in Q4 2025.
- For the quarter ending Q4 2025, Income from Continuing Operations rose 252.25% year-over-year to 309470000.0; the trailing twelve-month figure through Dec 2025 stood at 136348000.0 (up 136.23% YoY), and the FY2025 full-year result was 27919000.0, up 112.04% from the prior year.
- Income from Continuing Operations for Q4 2025 stood at 309470000.0, up from 275853000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 327898000.0 in Q2 2025, with the low at 750367000.0 in Q4 2023.
- Historically, Income from Continuing Operations has averaged 116997444.44 across 5 years, with a median of 121404220.0 in 2022.
- The largest YoY upside for Income from Continuing Operations was 321.33% in 2025 against a maximum downside of 99900.0% in 2025.
- Alvotech's Income from Continuing Operations stood at 254019000.0 in 2021, then sank by 332.15% to 589714000.0 in 2022, then declined by 27.24% to 750367000.0 in 2023, then soared by 72.91% to 203262000.0 in 2024, then surged by 252.25% to 309470000.0 in 2025.
- The last three Income from Continuing Operations figures came in at 309470000.0 (Q4 2025), 275853000.0 (Q3 2025), and 327898000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 21.05 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -92.12 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 118.42 Mn |
| 10 | Alvotech | - | - | -22.39 Mn | 309.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 309.47 Mn |
| Sep 30, 2025 | -275.85 Mn |
| Jun 30, 2025 | 327.90 Mn |
| Mar 31, 2025 | -225.17 Mn |
| Dec 31, 2024 | -203.26 Mn |
| Sep 30, 2024 | -24.75 Mn |
| Jun 30, 2024 | -148.15 Mn |
| Mar 31, 2024 | -225,167.00 |
| Dec 31, 2023 | -750.37 Mn |
| Aug 31, 2023 | -136.71 Mn |
| Jun 30, 2023 | -136.40 Mn |
| Mar 31, 2023 | -305,560.00 |
| Dec 31, 2022 | -589.71 Mn |
| Aug 31, 2022 | -201.54 Mn |
| Jun 30, 2022 | -106.41 Mn |
| Mar 31, 2022 | -95.14 Mn |
| Dec 31, 2021 | 254.02 Mn |
| Sep 30, 2021 | -103.35 Mn |